magNews

Corporate Industry Technology Medical Updates

Redefining New Boundaries in Delivering Patient Care

magAssist Recognized in 2024 VENTURE50 Awards

MoyoAssist® Extra-VAD® Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China

MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held

Corporate
Highlights｜magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application 2022-12-12
Corporate
magAssist founder Dr. Po-Lin HSU, was selected as 2022 Most Influential Business Women——Future by FORTUNE China 2022-11-03
Corporate
MoyoAssist®, the winning project for Australian Good Design Awards and Designer Australia Awards 2022. 2022-09-30
Corporate
magAssist is on the list of Forbes Asia 100 to Watch 2022 2022-09-09
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
Corporate
Fortune China recently released its 2022 list of China's most socially impactful startups, and magAssist is on the list. 2022-08-06
Corporate
magAssist named on List of 2022 Top 100 Emerging Advanced Medical Device Companies in China 2022-08-05
Corporate
magAssist partners with top universities to help nurture young talents 2022-07-16
Technology
magAssist participation in the 9th World Congress of Biomechanics 2022 2022-07-10
Corporate
Dr. Polin Hsu, has been elected as one of the 40 under 40 business elites by Fortune China. 2022-06-22

Tags： Innovation, Application, Extra-VAD, U.S. FDA, Interventional Ventricular Assist Device, Breakthrough Device, VENTURE50, Awards, Healthcare, Difference,